Page 4 - Cell Therapy Program News Today

RGI-2001 was well tolerated and associated with a meaningful reduction in the incidence of severe acute GvHD REGiMMUNE Limited, a clinical-stage biopharmaceutical company developing innovative

For the readers interested in the stock health of Rocket Pharmaceuticals Inc. (RCKT). It is currently valued at $17.23. When the transactions were called off in the previous session, Stock hit the highs of $17.575, after setting-off with the price of $17.33. Company’s stock value dipped to $16.54

In fall 2021, 31-year-old Katelyn McNamara and her husband Jonathan were set to leave the U.S. and embark on a new life in Germany. Their plans to move overseas were suddenly dashed by one word — cancer.

An experimental gene therapy for sickle cell disease restored blood cells to their normal shape and eliminated severe pain crises for years after treatment, a multicenter study has found.

A single dose restored blood cells to their normal shape and eliminated the most serious complication of sickle cell disease for at least three years in some pa

According to a study, a single dose restored blood cells to their normal shape and eliminated the most serious complication of sickle cell disease for at least three years in some patients.

According to a study, a single dose restored blood cells to their normal shape and eliminated the most serious complication of sickle cell disease for at least three years in some patients.

According to a study, a single dose restored blood cells to their normal shape and eliminated the most serious complication of sickle cell disease for at least

A study of an investigational gene therapy for sickle cell disease has found that a single dose restored blood cells to their normal shape and eliminated the most serious complication of the disease for at least three years in some patients.Four pati

A study of an investigational gene therapy for sickle cell disease has found that a single dose restored blood cells to their normal shape and